Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iShares Russell 2000 ETF (NY:IWM)

248.78 UNCHANGED
Streaming Delayed Price Updated: 8:00 PM EDT, Mar 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about iShares Russell 2000 ETF

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
HighMark Wealth Management Buys 158,855 Shares of Axogen Stock ↗
This healthcare firm delivers surgical solutions for peripheral nerve repair, targeting specialized surgeons across U.S. and global markets. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
CIFR Stock Is Gaining Retail Attention After Earnings Despite Revenue Miss – Here’s What Investors Are Watching ↗
Cipher’s fourth-quarter revenue came in at $60 million, significantly below the consensus estimates of $85.7 million, according to Fiscal.ai data. 
Via Stocktwits
Topics Bonds
News headline image
Axsome Therapeutics’ Q4 Numbers Beat Wall Street Expectations: Analyst Sees Over 23% Upside For Stock ↗
TD Cowen analyst Joseph Thome’s new price target represents a potential upside of about 23% from AXSM’s current trading levels. 
Via Stocktwits
Topics Artificial Intelligence
Small Caps Hold Up As Breadth Takes A Breather ↗
Via Chartmill
Breadth Improves, But the Weekly Picture Still Needs Repair ↗
Via Chartmill
Breadth Stalls Near Resistance as Mega-Caps Cool Off ↗
Via Chartmill
Breadth Stabilizes After Violent Reversal ↗
Via Chartmill
Breadth Takes a Hit as Sellers Return in Force ↗
Via Chartmill
News headline image
Bitcoin Sale Is Not A ‘Concern,’ No Plans To Stop Mining, Says Bitdeer – BTDR Stock Slips Overnight ↗
Bitdeer said on Monday that it plans to keep mining Bitcoin and anticipates that its hash rate will continue to grow. 
Via Stocktwits
Topics Artificial Intelligence Bankruptcy Earnings
News headline image
SVRA Stock Rises After Hours As FDA Grants Priority Review For Lung Disorder Therapy ↗
The company is seeking approval for Molbreevi to treat patients with Autoimmune Pulmonary Alveolar Proteinosis (autoimmune PAP). 
Via Stocktwits
Topics Intellectual Property Lawsuit
News headline image
VNDA Stock Rallies After-Hours As FDA Approves Schizophrenia, Bipolar Disorder Drug ↗
This is the second Vanda drug to be approved in the span of a few months, after the approval of Nereus in December. 
Via Stocktwits
News headline image
ARDX Stock Is Down Pre-Market After Q4 Earnings Miss, So Why Did This Firm Just Hike Price Target By 80%? ↗
Analysts at H.C. Wainwright hiked their price target for Ardelyx shares to $18 from $10. 
Via Stocktwits
Topics Earnings Intellectual Property
Breadth Rebound Holds - But Leadership Still Hesitates ↗
Via Chartmill
Breadth Cools Off, Uptrend Still Intact ↗
Via Chartmill
Breadth Holds Up After Friday’s Surge, But Momentum Cools ↗
Via Chartmill
News headline image
ImmunityBio Announces Partnership To Expand Access To Anktiva Across 30 Countries ↗
The company also announced the establishment of an Irish subsidiary in Dublin to support its distribution and commercialization strategy across Europe. 
Via Stocktwits
News headline image
LMND Stock Soars Pre-Market: Lemonade Extends Premium Growth Streak To Ninth Consecutive Quarter ↗
Lemonade reported a 31% year-on-year growth in In Force Premium to $1.24 billion in the fourth quarter. 
Via Stocktwits
Topics Government
News headline image
HRMY Stock Rises On Fresh FDA Approval For Wakix Tablets In Children But Wall Street Eyes Further Rally ↗
The FDA has approved Harmony’s Wakix tablets for the treatment of cataplexy in pediatric patients aged 6 years and older with narcolepsy. 
Via Stocktwits
News headline image
Why Is TRIP Stock Rallying Today? ↗
Starboard said that it believes that Tripadvisor should be formally exploring a sale of the entire company, in one or multiple transactions. 
Via Stocktwits
News headline image
Wall Street Pauses for Presidents Day as Record-Breaking Dow Faces Tech Sector Headwinds
NEW YORK — The floor of the New York Stock Exchange (NYSE: ICE) sits silent today, February 16, 2026, as the U.S. financial markets observe the Presidents Day holiday. While the closure provides a... 
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
We Don’t Predict. We Position: How Jon Turned $4K of Risk Into a $30K Return ↗
Learn options trading inside a system that values evidence, structure, and defined risk. A real member explains the difference. 
Via InvestorPlace
News headline image
Blueshift Dumps 34,000 CROX Shares Worth $2.9 Million ↗
Crocs designs and markets casual footwear and accessories for a global customer base, leveraging both retail and e-commerce channels. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
VOO Has Delivered Higher Returns, But IWM Provides Broad Small Cap Exposure ↗
Explore how IWM’s broader sector mix and unique small-cap focus set it apart from VOO’s concentrated large-cap approach. 
Via The Motley Fool
Topics ETFs
News headline image
Disc Medicine Stock Slumps After FDA Declines Approval For Inherited Disorder Drug Over Efficacy Concerns ↗
The FDA said in a letter to the company published on Friday that the data submitted by the company is insufficient proof of clinical benefit for bitopertin. 
Via Stocktwits
News headline image
NVCR Rallies On FDA Approval For Cancer Treatment Device, Analyst Still Sees 275% Potential Upside ↗
H.C. Wainwright raised the firm's price target on Novocure to $47 from $39 and kept a ‘Buy’ rating on the shares after the company announced FDA approval of Optune Pax. 
Via Stocktwits
Topics Government
News headline image
ARVN Stock Drops On CEO Exit — Retail Is Bullish On New Chief’s Credentials, Dismisses Selloff ↗
Randy Teel has been appointed as President, CEO, as well as a member of the Company’s Board of Directors, effective immediately. 
Via Stocktwits
News headline image
Upstart Stock Rallies 7% After-Hours Today — Who Is The New CEO? ↗
Upstart also reported total revenue of $296 million in its fourth quarter, a 35% jump from the year-ago quarter. 
Via Stocktwits
News headline image
Why Did RGNX Shares Plummet 19% After-Hours Today? ↗
REGENXBIO said on Monday that the U.S. Food and Drug Administration (FDA) denied approval for its gene therapy in treating Hunter syndrome, outlining several reasons for the denial. 
Via Stocktwits
News headline image
Upwork Stock Plummets 23% After-Hours Today – Here’s Why ↗
The company said it expects adjusted diluted EPS in the range of $0.26 to $0.28 for the first quarter of 2026, below analysts’ estimates of $0.32 per share, according to data from Fiscal.ai. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
Why Did CRDO Stock Rally After Hours Today? ↗
The company’s preliminary revenue numbers exceeded its own guidance provided earlier. 
Via Stocktwits
Topics Artificial Intelligence
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.